THE IMMUNE LANDSCAPE OF BLOOD DENDRITIC CELLS IN GLIOBLASTOMA MULTIFORME: IMPLICATIONS FOR DC VACCINATION COMBINED WITH CHECKPOINT INHIBITION

被引：0
|
作者：
Kong, Benjamin [1 ]
Kim, Julius [1 ]
Fromm, Phillip [1 ]
Bui, Kim Tam [2 ]
Linton, Anthony [3 ]
Kaufman, Kimberley [4 ]
Beale, Philip [2 ]
Buckland, Michael [5 ]
Clark, Georgina [1 ]
机构：
[1] ANZAC Res Inst, Concord, NSW, Australia
[2] Concord Repatriat Gen Hosp, Dept Med Oncol, Concord, NSW, Australia
[3] Concord Repatriat Gen Hosp, Concord, NSW, Australia
[4] Univ Sydney, Camperdown, NSW, Australia
[5] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-50
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [1] OVERVIEW OF THE GLITIPNI TRIAL - LOCAL ADMINISTRATION OF IMMUNE CHECKPOINT INHIBITION AND/ OR DENDRITIC CELLS FOLLOWING RESECTION OF RECURRENT GLIOBLASTOMA
    Duerinck, J.
    Tijtgat, J.
    Dirven, I.
    Geens, W.
    Brock, S.
    Michotte, A.
    Geeraerts, X.
    Stevens, L.
    Thuyaerts, S.
    Everaert, H.
    Vanbinst, A.
    Bruneau, M.
    Rogiers, A.
    Neyns, B.
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [2] Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies
    Zanotta, Serena
    Galati, Domenico
    De Filippi, Rosaria
    Pinto, Antonio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [3] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Heynckes, Sabrina
    Daka, Karam
    Franco, Pamela
    Gaebelein, Annette
    Frenking, Jan Hendrik
    Doria-Medina, Roberto
    Mader, Irina
    Delev, Daniel
    Schnell, Oliver
    Heiland, Dieter Henrik
    [J]. BMC CANCER, 2019, 19 (1)
  • [4] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Sabrina Heynckes
    Karam Daka
    Pamela Franco
    Annette Gaebelein
    Jan Hendrik Frenking
    Roberto Doria-Medina
    Irina Mader
    Daniel Delev
    Oliver Schnell
    Dieter Henrik Heiland
    [J]. BMC Cancer, 19
  • [5] Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
    Bouffet, Eric
    Larouche, Valerie
    Campbell, Brittany B.
    Merico, Daniele
    de Borja, Richard
    Aronson, Melyssa
    Durno, Carol
    Krueger, Joerg
    Cabric, Vanja
    Ramaswamy, Vijay
    Zhukova, Nataliya
    Mason, Gary
    Farah, Roula
    Afzal, Samina
    Yalon, Michal
    Rechavi, Gideon
    Magimairajan, Vanan
    Walsh, Michael F.
    Constantini, Shlomi
    Dvir, Rina
    Elhasid, Ronit
    Reddy, Alyssa
    Osborn, Michael
    Sullivan, Michael
    Hansford, Jordan
    Dodgshun, Andrew
    Klauber-Demore, Nancy
    Peterson, Lindsay
    Patel, Sunil
    Lindhorst, Scott
    Atkinson, Jeffrey
    Cohen, Zane
    Laframboise, Rachel
    Dirks, Peter
    Taylor, Michael
    Malkin, David
    Albrecht, Steffen
    Dudley, Roy W. R.
    Jabado, Nada
    Hawkins, Cynthia E.
    Shlien, Adam
    Tabori, Uri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2206 - +
  • [6] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Hunn, Martin K.
    Bauer, Evelyn
    Wood, Catherine E.
    Gasser, Olivier
    Dzhelali, Marina
    Ancelet, Lindsay R.
    Mester, Brigitta
    Sharples, Katrina J.
    Findlay, Michael P.
    Hamilton, David A.
    Hermans, Ian F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 319 - 329
  • [7] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Martin K. Hunn
    Evelyn Bauer
    Catherine E. Wood
    Olivier Gasser
    Marina Dzhelali
    Lindsay R. Ancelet
    Brigitta Mester
    Katrina J. Sharples
    Michael P. Findlay
    David A. Hamilton
    Ian F. Hermans
    [J]. Journal of Neuro-Oncology, 2015, 121 : 319 - 329
  • [8] On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
    Kong, Benjamin Y.
    Bolton, Holly
    Kim, Julius W.
    Silveira, Pablo A.
    Fromm, Phillip D.
    Clark, Georgina J.
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [9] Combination Immune Treatment of a Highly Aggressive Orthotopic Murine Glioblastoma With Checkpoint Blockade Inhibition and Neoantigen Vaccination
    Liu, Connor
    Schaettler, Maximilian
    Bowman-Kirigin, Jay
    Bender, Diane
    Kobayashi, Dale K.
    Miller, Chris A.
    Johanns, Tanner M.
    Dunn, Gavin P.
    [J]. NEUROSURGERY, 2019, 66 : 44 - 45
  • [10] In situ vaccination with CCL21-modified dendritic cells (CCL21-DC) combined with checkpoint blockade in murine models of NSCLC
    Lim, Raymond J.
    Salehirad, Ramin
    Liu, Bin
    Li, Rui
    Tran, Linh M.
    Krysan, Kostyantyn
    Ong, Stephanie
    Huang, Zi L.
    Shackelford, David B.
    Sharma, Sherven
    Dubinett, Steven M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345